Prostate cancer: STHLM3 model for prostate cancer screening
- PMID: 26597612
- DOI: 10.1038/nrurol.2015.286
Prostate cancer: STHLM3 model for prostate cancer screening
Comment on
-
Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.Lancet Oncol. 2015 Dec;16(16):1667-76. doi: 10.1016/S1470-2045(15)00361-7. Epub 2015 Nov 10. Lancet Oncol. 2015. PMID: 26563502
References
-
- Lancet Oncol. 2015 Dec;16(16):1667-76 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
